White label – Pompe disease - ClinicalTrials.eu

Study of GS030 gene therapy safety and tolerability in patients with Retinitis Pigmentosa

Recruiting

1 1 1
Investigated Diseases:
- Retinitis pigmentosa
Investigated Drugs:
- Adeno-Associated Viral Vector Serotype 2.7M8 Containing The Chrimsonr-Tdtomato Gene
Study on Isatuximab for Treating Pure Red Cell Aplasia in Patients with Major ABO Mismatch After Stem Cell Transplantation

Recruiting

2 1 1 1
Investigated Diseases:
- Aplasia pure red cell
Investigated Drugs:
- Isatuximab
Study for Patients with BRCA Mutated Ovarian, Breast, Pancreatic, Prostate, and Endometrial Cancers Continuing Olaparib Treatment

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
- Olaparib
+6
Study on the Effectiveness and Safety of Guselkumab for Children with Moderate to Severe Crohn’s Disease

Recruiting

3 1
Investigated Drugs:
- Guselkumab
+3
Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Squamous cell carcinoma of head and neck
Investigated Drugs:
Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+1
Comparison of General Anesthesia versus High-Flow Nasal Cannula Sedation in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Ischaemic stroke
Investigated Drugs:
Study on Preventing Cytomegalovirus Infection Using Valganciclovir in Kidney Transplant Patients

Recruiting

3 1 1 1
Investigated Drugs:
- Valganciclovir
Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Recruiting

3 1 1
Investigated Diseases:
- Irritable bowel syndrome
Study on M2RLAB Cell Therapy for Treating Acute Kidney Injury in Patients After Heart Surgery

Recruiting

2 1
Investigated Drugs:
- M2Rlab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies